Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system

Journal of Biological Chemistry

Volumn 290, Issue 20, 2015, Pages 12603-12613

  Kobayashi, Yuka ^a   Kiguchi, Norikazu ^a   Fukazawa, Yohji ^a   Saika, Fumihiro ^a   Maeda, Takehiko ^b   Kishioka, Shiroh ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CELLS; CYTOLOGY; HEALTH; HORMONES; LIGANDS; MACROPHAGES; PROTEINS; TUMORS;

BONE MARROW CELLS; ENHANCED GREEN FLUORESCENT PROTEIN; EXPRESSION LEVELS; INFLAMMATORY CYTOKINES; NEUROINFLAMMATION; NEUTRALIZING ANTIBODIES; T CELL ACTIVATION; TUMOR NECROSIS FACTORS;

T-CELLS;

CYTOKINE; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR LIGAND; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; TNFRSF18 PROTEIN, MOUSE; TNFSF18 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE RELEASE; HYPERALGESIA; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PARTIAL SCIATIC NERVE LIGATION INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL COMMUNICATION; DISEASE MODEL; DRUG EFFECTS; GENETICS; LYMPHOCYTE ACTIVATION; METABOLISM; NEURALGIA; PATHOLOGY; TRANSGENIC MOUSE;

MUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; CELL COMMUNICATION; CYTOKINES; DISEASE MODELS, ANIMAL; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, TRANSGENIC; NEURALGIA; T-LYMPHOCYTES; TUMOR NECROSIS FACTORS;

EID: 84929340861     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.636506     Document Type: Article

References (33)

1. Baron, R. (2006) Mechanisms of disease: neuropathic pain, a clinical perspective. Nat. Clin. Pract. Neurol. 2, 95-106
2. Campbell, J. N., and Meyer, R. A. (2006) Mechanisms of neuropathic pain. Neuron 52, 77-92
3. Marchand, F., Perretti, M., and McMahon, S. B. (2005) Role of the immune system in chronic pain. Nat. Rev. Neurosci. 6, 521-532
4. Calvo, M., Dawes, J. M., and Bennett, D. L. (2012) The role of the immune system in the generation of neuropathic pain. Lancet Neurol. 11, 629-642
5. Scholz, J., and Woolf, C. J. (2007) The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci. 10, 1361-1368
6. Thacker, M. A., Clark, A. K., Marchand, F., and McMahon, S. B. (2007) Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth. Analg. 105, 838-847
7. Kiguchi, N., Maeda, T., Kobayashi, Y., Fukazawa, Y., and Kishioka, S. (2010) Macrophage inflammatory protein-1α mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1β up-regulation. Pain 149, 305-315
8. Kiguchi, N., Kobayashi, Y., Maeda, T., Fukazawa, Y., Tohya, K., Kimura, M., and Kishioka, S. (2012) Epigenetic augmentation of the macrophage inflammatory protein 2/C-X-C chemokine receptor type 2 axis through histone H3 acetylation in injured peripheral nerves elicits neuropathic pain. J. Pharmacol. Exp. Ther. 340, 577-587
9. Saika, F., Kiguchi, N., Kobayashi, Y., Fukazawa, Y., and Kishioka, S. (2012) CC-chemokine ligand 4/macrophage inflammatory protein-1β participates in the induction of neuropathic pain after peripheral nerve injury. Eur. J. Pain 16, 1271-1280
10. Nocentini, G., Giunchi, L., Ronchetti, S., Krausz, L. T., Bartoli, A., Moraca, R., Migliorati, G., and Riccardi, C. (1997) A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A. 94, 6216-6221
11. Gurney, A. L., Marsters, S. A., Huang, R. M., Pitti, R. M., Mark, D. T., Baldwin, D. T., Gray, A. M., Dowd, A. D., Brush, A. D., Heldens, A. D., Schow, A. D., Goddard, A. D., Wood, W. I., Baker, K. P., Godowski, P. J., and Ashkenazi, A. (1999) Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr. Biol. 9, 215-218
12. Shevach, E. M., and Stephens, G. L. (2006) The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat. Rev. Immunol. 6, 613-618
13. Cuzzocrea, S., Nocentini, G., Di Paola, R., Agostini, M., Mazzon, E., Ronchetti, S., Crisafulli, C., Esposito, E., Caputi, A. P., and Riccardi, C. (2006) Proinflammatory role of glucocorticoid-induced TNF receptorrelated gene in acute lung inflammation. J. Immunol. 177, 631-641
14. You, S., Poulton, L., Cobbold, S., Liu, C. P., Rosenzweig, M., Ringler, D., Lee, W. H., Segovia, B., Bach, J. F., Waldmann, H., and Chatenoud, L. (2009) Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target. PLoS One 4, e7848
15. Seltzer, Z., Dubner, R., and Shir, Y. (1990) A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43, 205-218
16. Kobayashi,Y. K., Kiguchi, N., Maeda, T., Ozaki, M., and Kishioka, S. (2012) The critical role of spinal ceramide in the development of partial sciatic nerve ligation-induced neuropathic pain in mice. Biochem. Biophys. Res. Commun. 421, 318-322
17. Coste, O., Pierre, S., Marian, C., Brenneis, C., Angioni, C., Schmidt, H., Popp, L., Geisslinger, G., and Scholich, K. (2008) Antinociceptive activity of the S1P-receptor agonist FTY720. J. Cell Mol. Med. 12, 995-1004
18. Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., Foster, C. A., Zollinger, M., and Lynch, K. R. (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277, 21453-21457
19. Okada, Y., Reinach, P. S., Shirai, K., Kitano, A., Kao, W. W., Flanders, K. C., Miyajima, M., Liu, H., Zhang, J., and Saika, S. (2011) TRPV1 involvement in inflammatory tissue fibrosis in mice. Am. J. Pathol. 178, 2654-2664
20. Kiguchi, N., Kobayashi, Y., Maeda, T., Tominaga, S., Nakamura, J., Fukazawa, Y., Ozaki, M., and Kishioka, S. (2012) Activation of nicotinic acetylcholine receptors on bone marrow-derived cells relieves neuropathic pain accompanied by peripheral neuroinflammation. Neurochem. Int. 61, 1212-1219
21. Hargreaves, K., Dubner, R., Brown, F., Flores, C., and Joris, J. (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77-88
22. Van Rooijen, N., and Sanders, A. (1994) Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174, 83-93
23. Kiguchi, N., Kobayashi, Y., and Kishioka, S. (2012) Chemokines and cytokines in neuroinflammation leading to neuropathic pain. Curr. Opin. Pharmacol. 12, 55-61
24. Wei, X. H., Zang, Y., Wu, C. Y., Xu, J. T., Xin, W. J., and Liu, X. G. (2007) Peri-sciatic administration of recombinant rat TNF-α induces mechanical allodynia via upregulation of TNF-αl in dorsal root ganglia and in spinal dorsal horn: the role of NF-κB pathway. Exp. Neurol. 205, 471-484
25. Zelenka, M., Schäfers, M., and Sommer, C. (2005) Intraneural injection of interleukin-1β and tumor necrosis factor-α into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain 116, 257-263
26. Li, J. J., Zhou, X., and Yu, L. C. (2005) Involvement of neuropeptide Y and Y1 receptor in antinociception in the arcuate nucleus of hypothalamus, an immunohistochemical and pharmacological study in intact rats and rats with inflammation. Pain 118, 232-242
27. Kleinschnitz, C., Hofstetter, H. H., Meuth, S. G., Braeuninger, S., Sommer, C., and Stoll, G. (2006) T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression. Exp. Neurol. 200, 480-485
28. Steward-Tharp, S. M., Song, Y. J., Siegel, R. M., and O'Shea, J. J. (2010) New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression. Ann. N.Y. Acad. Sci. 1183, 123-148
29. Taniguchi, T., and Minami, Y. (1993) The IL-2/IL-2 receptor system: a current overview. Cell 73, 5-8
30. Hall, B. M., Verma, N. D., Tran, G. T., and Hodgkinson, S. J. (2011) Distinct regulatory CD4+ T cell subsets: differences between naive and antigen specific T regulatory cells. Curr. Opin. Immunol. 23, 641-647
31. Austin, P. J., Kim, C. F., Perera, C. J., and Moalem-Taylor, G. (2012) Regulatory T cells attenuate neuropathic pain following peripheral nerve injury and experimental autoimmune neuritis. Pain 153, 1916-1931
32. Nocentini, G., Cuzzocrea, S., Genovese, T., Bianchini, R., Mazzon, E., Ronchetti, S., Esposito, E., Rosanna, D. P., Bramanti, P., and Riccardi, C. (2008) Glucocorticoid-induced tumor necrosis factor receptor-related (GITR)-Fc fusion protein inhibits GITR triggering and protects from the inflammatory response after spinal cord injury. Mol. Pharmacol. 73, 1610-1621
33. Liao, G., van Driel, B., Magelky, E., O'Keeffe, M. S., de Waal Malefyt, R., Engel, P., Herzog, R. W., Mizoguchi, E., Bhan, A. K., and Terhorst, C. (2014) Glucocorticoid-induced TNF receptor family related protein ligand regulates the migration of monocytes to the inflamed intestine. FASEB J. 28, 474-484